cilostazol (Pletal)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Pletal.

Indications

Contraindications

Dosage

Pharmacokinetics

Adverse effects

Drug interactions

Mechanism of action

More general terms

Component of

References

  1. 1.0 1.1 Kaiser Permanente Northern California Regional Drug Formulary, Update 9/99
  2. 2.0 2.1 Prescriber's Letter 7(12):69 2000
  3. 3.0 3.1 Huang Y et al for the CASISP cooperation investigators. Cilostazol as an alternative to aspirin after ischaemic stroke: A randomized, double-blind, pilot study. Lancet Neurol 2008, 7:494 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18456558
    Hankey GJ Cilostazol shows promise as alternative to aspirin for patients with ischaemic stroke. Lancet Neurol 2008, 7:469 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18456559 (industry-sponsored)
  4. 4.0 4.1 Shinohara Y et al, Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial The Lancet Neurology, Early Online Publication, 11 September 2010doi:10.1016/S1474-4422(10)70198-8C <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20833591 <Internet> http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2810%2970198-8/abstract
  5. 5.0 5.1 Pande RL, Hiatt WR, Zhang P, Hittel N, Creager MA A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010 Jun;15(3):181-8 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20385711
  6. 6.0 6.1 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, 16, 17, 18. American College of Physicians, Philadelphia 1998, 2009, 2012, 2015, 2018.
  7. 7.0 7.1 7.2 Toyoda K et al. Association of timing for starting dual antiplatelet treatment with cilostazol and recurrent stroke: A CSPS.com trial post hoc analysis. Neurology 2022 Jan 24; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/35074890 https://n.neurology.org/content/early/2022/01/24/WNL.0000000000200064
  8. 8.0 8.1 Chien CG, Huang LC, Li KY, Yang YH. Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case-control study. Geriatrics Gerontology International. 2023. Jan 23 PMID: https://www.ncbi.nlm.nih.gov/pubmed/36682741 https://onlinelibrary.wiley.com/doi/abs/10.1111/ggi.14542

Database